These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1666298)

  • 21. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
    Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
    J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.
    Thomas JP; Moore T; Kraut EH; Balcerzak SP; Galloway S; Vandre DD;
    Cancer Invest; 2002; 20(2):192-8. PubMed ID: 11901539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase II study of lung cancer--evaluation of new drug in small cell lung cancer (SCLC) and phase II testing of analogues].
    Furuse K
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1499-503. PubMed ID: 1649580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Furtulon (doxifluridine) in the treatment of non-small cell bronchial carcinoma].
    Drings P; Calcanis A
    Onkologie; 1987 Dec; 10(6):376-7. PubMed ID: 2831491
    [No Abstract]   [Full Text] [Related]  

  • 25. Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory.
    Jensen PB; Sehested M; Langer SW; Hansen HH
    Cancer Treat Rev; 1999 Dec; 25(6):377-86. PubMed ID: 10644503
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).
    Hainsworth JD; Hande KR; Satterlee WG; Kuttesch J; Johnson DH; Grindey G; Jackson LE; Greco FA
    Cancer Res; 1989 Sep; 49(18):5217-20. PubMed ID: 2766290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.
    Ettinger DS; Finkelstein DM; Abeloff MD; Chang YC; Smith TJ; Oken MM; Ruckdeschel JC
    Invest New Drugs; 1990 May; 8(2):183-5. PubMed ID: 2166720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A phase II study of carboplatin in lung cancer. The Carboplatin Cooperative Study Group].
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2781-5. PubMed ID: 2843133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
    Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
    Creech RH; Stanley K; Vogl SE; Ettinger DS; Bonomi PD; Salazar O
    Cancer Treat Rep; 1982 Jun; 66(6):1417-9. PubMed ID: 6282460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating new drugs as first treatment in patients with small-cell carcinoma: guidelines for an ethical approach with implications for other chemotherapy-sensitive tumors.
    Cullen MH; Hilton C; Stuart NS
    J Clin Oncol; 1988 Aug; 6(8):1356-7. PubMed ID: 2842466
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
    Evans WK; Eisenhauer EA; Cormier Y; Ayoub J; Wierzbicki R; Laberge F; Shepherd FA
    J Clin Oncol; 1990 Mar; 8(3):390-5. PubMed ID: 2155309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
    Malik ST; Rayner H; Fletcher J; Slevin ML
    Cancer Treat Rep; 1987 Dec; 71(12):1291-2. PubMed ID: 2825993
    [No Abstract]   [Full Text] [Related]  

  • 34. [Quality of life of patients with small cell lung cancer can be improved by treatment with cytostatic agents].
    Bergman B
    Lakartidningen; 1992 May; 89(19):1681-5. PubMed ID: 1315895
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancer.
    Valdivieso M; Umsawasdi T; Spitzer G; Chiuten DF; Booser DJ; Dhingra HM; Bodey GP
    Am J Clin Oncol; 1984 Jun; 7(3):241-4. PubMed ID: 6328968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
    Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
    Myers JW; Von Hoff DD; Clark GM; Coltman CA
    Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
    [No Abstract]   [Full Text] [Related]  

  • 38. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer.
    Ettinger DS
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):27-9. PubMed ID: 11479894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of lung cancer. Small cell anaplastic cancer].
    Sörenson S
    Lakartidningen; 1979 May; 76(20):1930-1. PubMed ID: 221761
    [No Abstract]   [Full Text] [Related]  

  • 40. Subcutaneous interleukin-2 as initial therapy for patients with extensive small cell lung cancer: a phase II trial of Cancer and Leukemia Group B.
    Clamon G; Herndon J; Akerley W; Green M
    Lung Cancer; 1998 Jan; 19(1):25-9. PubMed ID: 9493137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.